Skip to content
value.today

Align Technology, Inc.: peers

Change the peers

Align Technology, Inc. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Bio-Rad Laboratories, Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for its exchange yet), so its valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Align Technology, Inc., Globus Medical, Inc., Insulet Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Penumbra, Inc., Zimmer Biomet Holdings, Inc., Integer Holdings Corporation side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureAlign Technology, Inc.base
ALGN · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Globus Medical, Inc.
GMED · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Insulet Corporation
PODD · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Bio-Rad Laboratories, Inc.
BIO · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Bruker Corporation
BRKR · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Penumbra, Inc.
PEN · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Zimmer Biomet Holdings, Inc.
ZBH · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Integer Holdings Corporation
ITGR · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$10.7 BOct 22, 2026 · Market data4th of 8$10.9 BOct 26, 2026 · Market data3rd of 8$10.4 BOct 27, 2026 · Market data5th of 8$9.5 BAug 1, 2026 · Market data6th of 8$9.1 BOct 27, 2026 · Market data7th of 8$12.8 BOct 27, 2026 · Market data2nd of 8$18.2 BOct 29, 2026 · Market data1st of 8$4.3 BOct 27, 2026 · Market data8th of 8$10.5 B8 ranked
Revenue (Better neither way: ranked highest first)$4.0 BFY2025 · SEC2nd of 8$2.9 BFY2025 · SEC4th of 8$2.7 BFY2025 · SEC5th of 8$2.6 BFY2025 · SEC6th of 8$3.4 BFY2025 · SEC3rd of 8$1.4 BFY2025 · SEC8th of 8$8.2 BFY2025 · SEC1st of 8$1.9 BFY2025 · SEC7th of 8$2.8 B8 ranked
Net income (Higher is better)$410 MFY2025 · SEC4th of 8$538 MFY2025 · SEC3rd of 8$247 MFY2025 · SEC5th of 8$760 MFY2025 · SEC1st of 8$-9 MFY2025 · SEC8th of 8$178 MFY2025 · SEC6th of 8$705 MFY2025 · SEC2nd of 8$103 MFY2025 · SEC7th of 8$329 M8 ranked
Employees (Better neither way: ranked highest first)20,290December 31, 2025 · Profile1st of 86,000December 31, 2025 · Profile6th of 85,400December 31, 2025 · Profile7th of 87,450December 31, 2025 · Profile5th of 811,085December 31, 2025 · Profile3rd of 84,700December 31, 2025 · Profile8th of 817,000December 31, 2025 · Profile2nd of 89,000As on 2021 · Profile4th of 88,2258 ranked
Growth
Revenue growth (Higher is better)+0.9%FY2025 · SEC7th of 828th31st+16.6%FY2025 · SEC3rd of 862nd74th+30.7%FY2025 · SEC1st of 877th87th+0.7%FY2025 · SEC8th of 827th31st+2.1%FY2025 · SEC6th of 831st35th+17.5%FY2025 · SEC2nd of 864th75th+7.2%FY2025 · SEC5th of 843rd53rd+8.0%FY2025 · SEC4th of 844th55th+7.6%8 ranked
Revenue growth, 3 years a year (Higher is better)+2.6%FY2025 · SEC7th of 835th43rd+42.2%FY2025 · SEC1st of 887th95th+27.5%FY2025 · SEC2nd of 879th90th-2.7%FY2025 · SEC8th of 820th24th+10.7%FY2025 · SEC5th of 855th71st+18.3%FY2025 · SEC3rd of 870th83rd+5.8%FY2025 · SEC6th of 844th56th+11.7%FY2025 · SEC4th of 857th73rd+11.2%8 ranked
Earnings per share growth (Higher is better)+0.5%FY2025 · SEC2nd of 538th38th+422.7%FY2025 · SEC1st of 597th98th-39.8%FY2025 · SEC5th of 512th13th————————————-19.9%FY2025 · SEC4th of 522nd21st-14.0%FY2025 · SEC3rd of 524th25th-14.0%5 ranked
Margins and returns
Gross margin (Higher is better)67.2%FY2025 · SEC4th of 863rd80th67.4%FY2025 · SEC3rd of 864th80th71.6%FY2025 · SEC1st of 871st84th51.9%FY2025 · SEC6th of 839th66th45.9%FY2025 · SEC7th of 831st59th67.1%FY2025 · SEC5th of 863rd80th69.7%FY2025 · SEC2nd of 868th82nd27.0%FY2025 · SEC8th of 813th30th67.2%8 ranked
Operating margin (Higher is better)13.5%FY2025 · SEC3rd of 880th76th16.3%FY2025 · SEC2nd of 883rd80th17.5%FY2025 · SEC1st of 885th82nd1.8%FY2025 · SEC8th of 861st45th2.0%FY2025 · SEC7th of 861st45th13.5%FY2025 · SEC4th of 880th75th13.3%FY2025 · SEC5th of 879th75th11.9%FY2025 · SEC6th of 876th73rd13.4%8 ranked
Net margin (Higher is better)10.2%FY2025 · SEC4th of 880th75th18.3%FY2025 · SEC2nd of 889th87th9.1%FY2025 · SEC5th of 878th73rd29.4%FY2025 · SEC1st of 894th94th-0.3%FY2025 · SEC8th of 860th42nd12.7%FY2025 · SEC3rd of 882nd80th8.6%FY2025 · SEC6th of 877th71st5.5%FY2025 · SEC7th of 871st63rd9.6%8 ranked
Free cash flow margin (Higher is better)12.2%FY2025 · SEC6th of 875th75th20.0%FY2025 · SEC1st of 888th88th13.9%FY2025 · SEC4th of 879th79th14.5%FY2025 · SEC3rd of 880th80th1.3%FY2025 · SEC8th of 855th39th12.5%FY2025 · SEC5th of 876th75th17.9%FY2025 · SEC2nd of 885th85th5.7%FY2025 · SEC7th of 864th56th13.2%8 ranked
Return on equity (Higher is better)10.4%FY2025 · SEC5th of 881st66th12.3%FY2025 · SEC3rd of 884th72nd18.1%FY2025 · SEC1st of 889th83rd10.8%FY2025 · SEC4th of 882nd68th-0.4%FY2025 · SEC8th of 872nd41st13.8%FY2025 · SEC2nd of 886th75th5.6%FY2025 · SEC7th of 877th52nd6.1%FY2025 · SEC6th of 877th53rd10.6%8 ranked
Return on invested capital (Higher is better)————————————0.5%FY2025 · SEC3rd of 34th2nd————————5.1%FY2025 · SEC2nd of 318th17th6.6%FY2025 · SEC1st of 326th27th5.1%3 ranked
Valuation
P/E ratio (Better neither way: ranked highest first)21.7×price Oct 22, 2026 · Market data5th of 634th57th19.6×price Oct 26, 2026 · Market data6th of 631st51st24.1×price Oct 27, 2026 · Market data3rd of 641st62nd9.3×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price————81.6×price Oct 27, 2026 · Market data1st of 685th93rd23.8×price Oct 29, 2026 · Market data4th of 641st61st41.5×price Oct 27, 2026 · Market data2nd of 665th83rd24.0×6 ranked
Price to sales (Better neither way: ranked highest first)2.6×price Oct 22, 2026 · Market data5th of 739th55th3.5×price Oct 26, 2026 · Market data2nd of 749th66th3.3×price Oct 27, 2026 · Market data3rd of 746th63rd3.7×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price2.6×price Oct 27, 2026 · Market data4th of 740th55th8.2×price Oct 27, 2026 · Market data1st of 770th87th2.1×price Oct 29, 2026 · Market data7th of 734th50th2.4×price Oct 27, 2026 · Market data6th of 737th53rd2.6×7 ranked
Price to book (Better neither way: ranked highest first)2.6×price Oct 22, 2026 · Market data4th of 744th57th2.4×price Oct 26, 2026 · Market data6th of 742nd54th6.8×price Oct 27, 2026 · Market data2nd of 776th83rd1.3×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price3.7×price Oct 27, 2026 · Market data3rd of 757th69th9.0×price Oct 27, 2026 · Market data1st of 782nd88th1.4×price Oct 29, 2026 · Market data7th of 728th35th2.5×price Oct 27, 2026 · Market data5th of 743rd55th2.6×7 ranked
Free cash flow yield (Higher is better)4.6%price Oct 22, 2026 · Market data3rd of 785th64th5.4%price Oct 26, 2026 · Market data2nd of 788th68th3.6%price Oct 27, 2026 · Market data4th of 781st58th3.9%price Aug 1, 2026 · Market datanot ranked: old priceold priceold price0.5%price Oct 27, 2026 · Market data7th of 770th39th1.4%price Oct 27, 2026 · Market data6th of 773rd43rd8.1%price Oct 29, 2026 · Market data1st of 793rd81st2.4%price Oct 27, 2026 · Market data5th of 777th49th3.6%7 ranked
Financial strength
Debt to equity (Lower is better)————————————0.2×FY2025 · SEC1st of 429th20th0.8×FY2025 · SEC4th of 468th59th————0.6×FY2025 · SEC2nd of 456th47th0.7×FY2025 · SEC3rd of 463rd54th0.6×4 ranked
Net debt to EBITDA (Lower is better)————————————3.2×FY2025 · SEC2nd of 469th65th5.4×FY2025 · SEC4th of 485th84th————2.9×FY2025 · SEC1st of 468th61st3.3×FY2025 · SEC3rd of 472nd66th3.2×4 ranked
Interest cover (Higher is better)————————————1.0×FY2025 · SEConly one with it75th53rd————————————————1.0×—
Piotroski F-score (Higher is better)————6 of 9FY2025 · SEC1st of 55 of 9FY2025 · SEC2nd of 54 of 9FY2025 · SEC5th of 5——5 of 9FY2025 · SEC2nd of 55 of 9FY2025 · SEC2nd of 55.0 of 95 ranked
Scorecard
Scorecard (Higher is better)13 of 23FY2025 · Scorecard6th of 818 of 23FY2025 · Scorecard1st of 816 of 23FY2025 · Scorecard3rd of 810 of 20FY2025 · Scorecard7th of 811 of 26FY2025 · Scorecard8th of 813 of 22FY2025 · Scorecard5th of 822 of 29FY2025 · Scorecard2nd of 816 of 26FY2025 · Scorecard4th of 860% passed8 ranked
Valuation checks (Higher is better)1 of 6FY2025 · Scorecard3rd of 74 of 6FY2025 · Scorecard1st of 71 of 6FY2025 · Scorecard3rd of 7——0 of 6FY2025 · Scorecard6th of 70 of 6FY2025 · Scorecard6th of 74 of 6FY2025 · Scorecard1st of 71 of 6FY2025 · Scorecard3rd of 717% passed7 ranked
Growth checks (Higher is better)3 of 6FY2025 · Scorecard6th of 86 of 6FY2025 · Scorecard1st of 85 of 6FY2025 · Scorecard3rd of 82 of 6FY2025 · Scorecard8th of 83 of 6FY2025 · Scorecard6th of 86 of 6FY2025 · Scorecard1st of 84 of 6FY2025 · Scorecard5th of 85 of 6FY2025 · Scorecard3rd of 875% passed8 ranked
Profitability checks (Higher is better)3 of 5FY2025 · Scorecard4th of 83 of 5FY2025 · Scorecard4th of 85 of 5FY2025 · Scorecard1st of 82 of 6FY2025 · Scorecard7th of 81 of 5FY2025 · Scorecard8th of 83 of 5FY2025 · Scorecard4th of 84 of 6FY2025 · Scorecard2nd of 84 of 6FY2025 · Scorecard2nd of 860% passed8 ranked
Financial health checks (Higher is better)3 of 3FY2025 · Scorecard1st of 83 of 3FY2025 · Scorecard1st of 83 of 3FY2025 · Scorecard1st of 84 of 6FY2025 · Scorecard8th of 84 of 5FY2025 · Scorecard6th of 83 of 3FY2025 · Scorecard1st of 85 of 5FY2025 · Scorecard1st of 84 of 5FY2025 · Scorecard6th of 8100% passed8 ranked
Shareholder returns checks (Higher is better)3 of 3FY2025 · Scorecard1st of 82 of 3FY2025 · Scorecard5th of 82 of 3FY2025 · Scorecard5th of 82 of 2FY2025 · Scorecard1st of 83 of 4FY2025 · Scorecard4th of 81 of 2FY2025 · Scorecard8th of 85 of 6FY2025 · Scorecard3rd of 82 of 3FY2025 · Scorecard5th of 871% passed8 ranked
Ownership
Held by institutions (Better neither way: ranked highest first)101.8%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 889.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 8106.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 866.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 887.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 888.7%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 898.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 8115.6%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 893.6%8 ranked
Institutions holding (Better neither way: ranked highest first)6192026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 86152026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 86932026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 84172026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 84362026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 84322026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 89342026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 83522026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 85268 ranked
Institutional holding, change over the quarter (Better neither way: ranked highest first)+6.1 pp2026-Q2 against 2026-Q1 · 13F2nd of 6+8.3 pp2026-Q2 against 2026-Q1 · 13F1st of 6+3.0 pp2026-Q2 against 2026-Q1 · 13F5th of 6————+0.6 pp2026-Q2 against 2026-Q1 · 13F6th of 6+4.9 pp2026-Q2 against 2026-Q1 · 13F4th of 6+5.0 pp2026-Q2 against 2026-Q1 · 13F3rd of 6+4.9 pp6 ranked
Dividends
Dividend yield (Higher is better)————————————————0.3%FY2025 · SEC2nd of 223rd9th————1.0%FY2025 · SEC1st of 253rd28th————0.6%2 ranked
Shareholder yield (Higher is better)4.4%FY2025 · SEC1st of 773rd63rd2.8%FY2025 · SEC3rd of 757th45th0.6%FY2025 · SEC5th of 726th16th3.1%FY2025 · SECnot ranked: old priceold priceold price0.4%FY2025 · SEC6th of 723rd13th0.0%FY2025 · SEC7th of 77th3rd3.7%FY2025 · SEC2nd of 767th56th1.2%FY2025 · SEC4th of 736th24th1.2%7 ranked
Dividend payout (Better neither way: ranked highest first)————————————————————————27.0%FY2025 · SEConly one with it46th34th————27.0%—
Dividend per share (Better neither way: ranked highest first)————————————$0.96FY2025 · SEConly one with it——$0.96—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Align Technology, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Globus Medical, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Insulet Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Bio-Rad Laboratories, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Bruker Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Penumbra, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Zimmer Biomet Holdings, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Integer Holdings Corporation: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Align Technology, Inc.13.5%FY2025
80th percentile in Healthcaremedian -7.7%, 674 companies
76th percentile in USAmedian 3.5%, 2,594 companies
Globus Medical, Inc.16.3%FY2025
83rd percentile in Healthcaremedian -7.7%, 674 companies
80th percentile in USAmedian 3.5%, 2,594 companies
Insulet Corporation17.5%FY2025
85th percentile in Healthcaremedian -7.7%, 674 companies
82nd percentile in USAmedian 3.5%, 2,594 companies
Bio-Rad Laboratories, Inc.1.8%FY2025
61st percentile in Healthcaremedian -7.7%, 674 companies
45th percentile in USAmedian 3.5%, 2,594 companies
Bruker Corporation2.0%FY2025
61st percentile in Healthcaremedian -7.7%, 674 companies
45th percentile in USAmedian 3.5%, 2,594 companies
Penumbra, Inc.13.5%FY2025
80th percentile in Healthcaremedian -7.7%, 674 companies
75th percentile in USAmedian 3.5%, 2,594 companies
Zimmer Biomet Holdings, Inc.13.3%FY2025
79th percentile in Healthcaremedian -7.7%, 674 companies
75th percentile in USAmedian 3.5%, 2,594 companies
Integer Holdings Corporation11.9%FY2025
76th percentile in Healthcaremedian -7.7%, 674 companies
73rd percentile in USAmedian 3.5%, 2,594 companies

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$2.1 B$4.1 B$6.2 B$8.2 B20102012201420162018202020222024Align Technology, Inc. $4.0 BGlobus Medical, Inc. $2.9 BInsulet Corporation $2.7 BBio-Rad Laboratories, Inc. $2.6 BBruker Corporation $3.4 BPenumbra, Inc. $1.4 BZimmer Biomet Holdings, Inc. $8.2 BInteger Holdings Corporation $1.9 B

Rank in the group

1st2nd3rd4th5th6th7th8th201120122013201420152016201720182019202020212022202320242025Align Technology, Inc.: 5th of 7 in 2011Align Technology, Inc.: 5th of 7 in 2012Align Technology, Inc.: 5th of 8 in 2013Align Technology, Inc.: 4th of 8 in 2014Align Technology, Inc.: 4th of 8 in 2015Align Technology, Inc.: 4th of 8 in 2016Align Technology, Inc.: 4th of 8 in 2017Align Technology, Inc.: 3rd of 8 in 2018Align Technology, Inc.: 2nd of 8 in 2019Align Technology, Inc.: 3rd of 8 in 2020Align Technology, Inc.: 2nd of 8 in 2021Align Technology, Inc.: 2nd of 8 in 2022Align Technology, Inc.: 2nd of 8 in 2023Align Technology, Inc.: 2nd of 8 in 2024Align Technology, Inc.: 2nd of 8 in 2025Align Technology, Inc.Globus Medical, Inc.: 6th of 7 in 2011Globus Medical, Inc.: 6th of 7 in 2012Globus Medical, Inc.: 6th of 8 in 2013Globus Medical, Inc.: 6th of 8 in 2014Globus Medical, Inc.: 6th of 8 in 2015Globus Medical, Inc.: 6th of 8 in 2016Globus Medical, Inc.: 6th of 8 in 2017Globus Medical, Inc.: 6th of 8 in 2018Globus Medical, Inc.: 6th of 8 in 2019Globus Medical, Inc.: 7th of 8 in 2020Globus Medical, Inc.: 7th of 8 in 2021Globus Medical, Inc.: 7th of 8 in 2022Globus Medical, Inc.: 6th of 8 in 2023Globus Medical, Inc.: 5th of 8 in 2024Globus Medical, Inc.: 4th of 8 in 2025Globus Medical, Inc.Insulet Corporation: 7th of 7 in 2011Insulet Corporation: 7th of 7 in 2012Insulet Corporation: 7th of 8 in 2013Insulet Corporation: 7th of 8 in 2014Insulet Corporation: 7th of 8 in 2015Insulet Corporation: 7th of 8 in 2016Insulet Corporation: 7th of 8 in 2017Insulet Corporation: 7th of 8 in 2018Insulet Corporation: 7th of 8 in 2019Insulet Corporation: 6th of 8 in 2020Insulet Corporation: 6th of 8 in 2021Insulet Corporation: 6th of 8 in 2022Insulet Corporation: 5th of 8 in 2023Insulet Corporation: 6th of 8 in 2024Insulet Corporation: 5th of 8 in 2025Insulet CorporationBio-Rad Laboratories, Inc.: 2nd of 7 in 2011Bio-Rad Laboratories, Inc.: 2nd of 7 in 2012Bio-Rad Laboratories, Inc.: 2nd of 8 in 2013Bio-Rad Laboratories, Inc.: 2nd of 8 in 2014Bio-Rad Laboratories, Inc.: 2nd of 8 in 2015Bio-Rad Laboratories, Inc.: 2nd of 8 in 2016Bio-Rad Laboratories, Inc.: 2nd of 8 in 2017Bio-Rad Laboratories, Inc.: 2nd of 8 in 2018Bio-Rad Laboratories, Inc.: 3rd of 8 in 2019Bio-Rad Laboratories, Inc.: 2nd of 8 in 2020Bio-Rad Laboratories, Inc.: 3rd of 8 in 2021Bio-Rad Laboratories, Inc.: 3rd of 8 in 2022Bio-Rad Laboratories, Inc.: 4th of 8 in 2023Bio-Rad Laboratories, Inc.: 4th of 8 in 2024Bio-Rad Laboratories, Inc.: 6th of 8 in 2025Bio-Rad Laboratories, Inc.Bruker Corporation: 3rd of 7 in 2011Bruker Corporation: 3rd of 7 in 2012Bruker Corporation: 3rd of 8 in 2013Bruker Corporation: 3rd of 8 in 2014Bruker Corporation: 3rd of 8 in 2015Bruker Corporation: 3rd of 8 in 2016Bruker Corporation: 3rd of 8 in 2017Bruker Corporation: 4th of 8 in 2018Bruker Corporation: 4th of 8 in 2019Bruker Corporation: 4th of 8 in 2020Bruker Corporation: 4th of 8 in 2021Bruker Corporation: 4th of 8 in 2022Bruker Corporation: 3rd of 8 in 2023Bruker Corporation: 3rd of 8 in 2024Bruker Corporation: 3rd of 8 in 2025Bruker CorporationPenumbra, Inc.: 8th of 8 in 2013Penumbra, Inc.: 8th of 8 in 2014Penumbra, Inc.: 8th of 8 in 2015Penumbra, Inc.: 8th of 8 in 2016Penumbra, Inc.: 8th of 8 in 2017Penumbra, Inc.: 8th of 8 in 2018Penumbra, Inc.: 8th of 8 in 2019Penumbra, Inc.: 8th of 8 in 2020Penumbra, Inc.: 8th of 8 in 2021Penumbra, Inc.: 8th of 8 in 2022Penumbra, Inc.: 8th of 8 in 2023Penumbra, Inc.: 8th of 8 in 2024Penumbra, Inc.: 8th of 8 in 2025Penumbra, Inc.Zimmer Biomet Holdings, Inc.: 1st of 7 in 2011Zimmer Biomet Holdings, Inc.: 1st of 7 in 2012Zimmer Biomet Holdings, Inc.: 1st of 8 in 2013Zimmer Biomet Holdings, Inc.: 1st of 8 in 2014Zimmer Biomet Holdings, Inc.: 1st of 8 in 2015Zimmer Biomet Holdings, Inc.: 1st of 8 in 2016Zimmer Biomet Holdings, Inc.: 1st of 8 in 2017Zimmer Biomet Holdings, Inc.: 1st of 8 in 2018Zimmer Biomet Holdings, Inc.: 1st of 8 in 2019Zimmer Biomet Holdings, Inc.: 1st of 8 in 2020Zimmer Biomet Holdings, Inc.: 1st of 8 in 2021Zimmer Biomet Holdings, Inc.: 1st of 8 in 2022Zimmer Biomet Holdings, Inc.: 1st of 8 in 2023Zimmer Biomet Holdings, Inc.: 1st of 8 in 2024Zimmer Biomet Holdings, Inc.: 1st of 8 in 2025Zimmer Biomet Holdings, InInteger Holdings Corporation: 4th of 7 in 2011Integer Holdings Corporation: 4th of 7 in 2012Integer Holdings Corporation: 4th of 8 in 2013Integer Holdings Corporation: 5th of 8 in 2014Integer Holdings Corporation: 5th of 8 in 2015Integer Holdings Corporation: 5th of 8 in 2016Integer Holdings Corporation: 5th of 8 in 2017Integer Holdings Corporation: 5th of 8 in 2018Integer Holdings Corporation: 5th of 8 in 2019Integer Holdings Corporation: 5th of 8 in 2020Integer Holdings Corporation: 5th of 8 in 2021Integer Holdings Corporation: 5th of 8 in 2022Integer Holdings Corporation: 7th of 8 in 2023Integer Holdings Corporation: 7th of 8 in 2024Integer Holdings Corporation: 7th of 8 in 2025Integer Holdings Corporati
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearAlign Technology, Inc.Globus Medical, Inc.Insulet CorporationBio-Rad Laboratories, Inc.Bruker CorporationPenumbra, Inc.Zimmer Biomet Holdings, Inc.Integer Holdings Corporation
2025$4.0 BSEC2nd$2.9 BSEC4th$2.7 BSEC5th$2.6 BSEC6th$3.4 BSEC3rd$1.4 BSEC8th$8.2 BSEC1st$1.9 BSEC7th
2024$4.0 BSEC2nd$2.5 BSEC5th$2.1 BSEC6th$2.6 BSEC4th$3.4 BSEC3rd$1.2 BSEC8th$7.7 BSEC1st$1.7 BSEC7th
2023$3.9 BSEC2nd$1.6 BSEC6th$1.7 BSEC5th$2.7 BSEC4th$3.0 BSEC3rd$1.1 BSEC8th$7.4 BSEC1st$1.6 BSEC7th
2022$3.7 BSEC2nd$1.0 BSEC7th$1.3 BSEC6th$2.8 BSEC3rd$2.5 BSEC4th$847 MSEC8th$6.9 BSEC1st$1.3 BSEC5th
2021$4.0 BSEC2nd$958 MSEC7th$1.1 BSEC6th$2.9 BSEC3rd$2.4 BSEC4th$748 MSEC8th$6.8 BSEC1st$1.2 BSEC5th
2020$2.5 BSEC3rd$789 MSEC7th$904 MSEC6th$2.5 BSEC2nd$2.0 BSEC4th$560 MSEC8th$6.1 BSEC1st$1.1 BSEC5th
2019$2.4 BSEC2nd$785 MSEC6th$738 MSEC7th$2.3 BSEC3rd$2.1 BSEC4th$547 MSEC8th$7.0 BSEC1st$1.3 BSEC5th
2018$2.0 BSEC3rd$713 MSEC6th$564 MSEC7th$2.3 BSEC2nd$1.9 BSEC4th$445 MSEC8th$7.9 BSEC1st$1.2 BSEC5th
2017$1.5 BSEC4th$636 MSEC6th$464 MSEC7th$2.2 BSEC2nd$1.8 BSEC3rd$334 MSEC8th$7.8 BSEC1st$1.1 BSEC5th
2016$1.1 BSEC4th$564 MSEC6th$367 MSEC7th$2.1 BSEC2nd$1.6 BSEC3rd$263 MSEC8th$7.7 BSEC1st$1.1 BSEC5th
2015$845 MSEC4th$545 MSEC6th$264 MSEC7th$2.0 BSEC2nd$1.6 BSEC3rd$186 MSEC8th$6.0 BSEC1st$800 MSEC5th
2014$762 MSEC4th$474 MSEC6th$231 MSEC7th$2.2 BSEC2nd$1.8 BSEC3rd$126 MSEC8th$4.7 BSEC1st$688 MSEC5th

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Align Technology, Inc.#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Globus Medical, Inc.GMED · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $10.9 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $10.9 B (Oct 26, 2026) · revenue $2.9 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • Insulet CorporationPODD · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $10.4 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $10.4 B (Oct 27, 2026) · revenue $2.7 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • Bio-Rad Laboratories, Inc.BIO · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $9.5 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $9.5 B (Aug 1, 2026) · revenue $2.6 B (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Bruker CorporationBRKR · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $9.1 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $9.1 B (Oct 27, 2026) · revenue $3.4 B (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Penumbra, Inc.PEN · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $12.8 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $12.8 B (Oct 27, 2026) · revenue $1.4 B (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Zimmer Biomet Holdings, Inc.ZBH · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $18.2 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $18.2 B (Oct 29, 2026) · revenue $8.2 B (year to December 2025)
    96 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    In the group
  • Integer Holdings CorporationITGR · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $4.3 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $4.3 B (Oct 27, 2026) · revenue $1.9 B (year to December 2025)
    94 of 100 (industry or sector 50 + size 24 + country 15 + figures on file 5)
    In the group
  • AxoGen, Inc.AXGN · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $3.0 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $3.0 B (Oct 30, 2026) · revenue $225 M (year to December 2025)
    92 of 100 (industry or sector 50 + size 22 + country 15 + figures on file 5)
    + Add
  • TransMedics Group, Inc.TMDX · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $2.5 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $2.5 B (Oct 27, 2026) · revenue $605 M (year to December 2025)
    90 of 100 (industry or sector 50 + size 20 + country 15 + figures on file 5)
    + Add
  • Edwards Lifesciences CorporationEW · 🇺🇸 USA
    Same industry: Medical Devices · Similar size: $52.8 B market cap against $10.7 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $52.8 B (Oct 29, 2026) · revenue $6.1 B (year to December 2025)
    90 of 100 (industry or sector 50 + size 20 + country 15 + figures on file 5)
    + Add
  • Butterfly Network, Inc.BFLY · 🇺🇸 USA
    Same industry: Medical Devices · 5.1× smaller by market cap · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $2.1 B (Oct 29, 2026) · revenue $98 M (year to December 2025)
    89 of 100 (industry or sector 50 + size 19 + country 15 + figures on file 5)
    + Add
  • Inspire Medical Systems, Inc.INSP · 🇺🇸 USA
    Same industry: Medical Devices · 5.2× smaller by market cap · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $2.1 B (Oct 21, 2026) · revenue $912 M (year to December 2025)
    89 of 100 (industry or sector 50 + size 19 + country 15 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.